Mereo BioPharma Group PLC (MREO)
4.01
-0.27
(-6.31%)
USD |
NASDAQ |
Nov 04, 16:00
4.025
+0.02
(+0.37%)
After-Hours: 20:00
Mereo BioPharma Group Net Income (Quarterly): -12.26M for June 30, 2024
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | -12.26M |
March 31, 2024 | -8.951M |
Date | Value |
---|---|
June 30, 2023 | -1.751M |
March 31, 2023 | -12.08M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-12.26M
Minimum
Jun 2024
-1.751M
Maximum
Jun 2023
-8.758M
Average
-10.51M
Median
Net Income (Quarterly) Benchmarks
NuCana PLC | -8.826M |
TC BioPharm (Holdings) PLC | -4.213M |
Adaptimmune Therapeutics PLC | 69.52M |
Biodexa Pharmaceuticals PLC | -- |
Bicycle Therapeutics PLC | -50.80M |
Net Income (Quarterly) Related Metrics
Total Expenses (Quarterly) | 12.44M |
EPS Diluted (Quarterly) | -0.10 |
Enterprise Value | 534.45M |
Earnings Yield | -6.58% |